The Utilization of Low Dose Naltrexone for Chronic Pain (Abstract)
The Utilization of Low Dose Naltrexone for Chronic Pain CNS Drugs 28 July 2023 https://pubmed.ncbi.nlm.nih.gov/37505425/ Naltrexone is a mu-opioid receptor antagonist with a long half-life compared with naloxone. Both of these drugs, along with others, were developed with the intention of reversing the effects of opioid abuse or toxicity. Evidence has also shown that naltrexone […]
Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions… (Abstract)
Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions – A Scoping Review Pain Med 11 June 2023 https://pubmed.ncbi.nlm.nih.gov/37302106/ Background: At low doses, naltrexone (LDN) has been shown to modulate inflammation through the interruption of microglial cell activation within the central nervous system. One of the most likely contributors to centralized pain is changes in […]
Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series (Abstract)
Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series J Pain Res 14 June 2023 https://pubmed.ncbi.nlm.nih.gov/37337611/ Purpose: Low-dose naltrexone (LDN) has increased in popularity as a non-opioid medication that may decrease chronic pain symptoms. LDN is most commonly used to treat fibromyalgia, complex regional pain syndrome (CRPS), and painful diabetic neuropathy. […]
Opiate Antagonists for Chronic Pain… (Abstract)
Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases Biomedicines 02 June 2023 https://pubmed.ncbi.nlm.nih.gov/37371715/ Chronic pain conditions create major financial and emotional burdens that can be devastating for individuals and society. One primary source of pain is arthritis, a common inflammatory disease of the joints that […]
Long-Term Effects of Low-Dose Naltrexone on Immunomodulatory Properties of … (Abstract)
Long-Term Effects of Low-Dose Naltrexone on Immunomodulatory Properties of Human Adipose-Derived Mesenchymal Stem Cells Iran J Immunol 31 May 2023 https://pubmed.ncbi.nlm.nih.gov/37151015/ Background: Low-dose naltrexone (LDN) is involved in the treatment of inflammatory and immune system diseases and can affect immune cells. Mesenchymal stem cells (MSCs) are known for their immunomodulatory effects and the potential for […]
Acute Low Dose Naltrexone Increases β-Endorphin and Promotes Neuronal Recovery … (Abstract)
Acute Low Dose Naltrexone Increases β-Endorphin and Promotes Neuronal Recovery Following Hypoxia-Ischemic Stroke in Type-2 Diabetic Mice Neurochem Res 11 May 2023 https://pubmed.ncbi.nlm.nih.gov/37166576/ Diabetic patients experience significant mortality and poor recovery following ischemic stroke. Our clinical and basic science studies demonstrate an overall immune suppression in the periphery of diabetic stroke patients, as well as […]
A systematic literature review on the clinical efficacy of low dose naltrexone … (Abstract)
A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia Heliyon 19 April 2023 https://pubmed.ncbi.nlm.nih.gov/37206027/ Background: Low dose naltrexone (LDN) is used off-label by many individuals with fibromyalgia to help manage their pain. There is no current systematic literature review summarising […]
Low-Dose Naltrexone in Rheumatological Diseases (Abstract)
Low-Dose Naltrexone in Rheumatological Diseases Mediterr J Rheumatol 31 March 2023 https://pubmed.ncbi.nlm.nih.gov/37223594/ Background: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders. Aim: To review the use of LDN in rheumatic diseases: systemic […]
Segmental Darier’s disease: A case report (Abstract)
Segmental Darier’s disease: A case report SAGE Open Med Case Rep 03 April 2023 https://pubmed.ncbi.nlm.nih.gov/37032996/ Segmental Darier’s disease is an uncommon subtype of Darier’s genodermatosis, resulting from a mutation in the ATPase type 2 during early embryogenesis. It typically presents as a persistent, pruritic papular eruption following the lines of Blaschko. Histopathology of Darier’s disease […]
Pilot Study of Low-Dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: … (Abstract)
Pilot Study of Low-Dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-Controlled, Crossover Clinical Trial Clin Ther 10 April 2023 https://pubmed.ncbi.nlm.nih.gov/37045708/ Purpose: Low-dose naltrexone (LDN) is commonly used to control pain and other symptoms, especially in patients with autoimmune diseases, but with limited evidence. This study tests the efficacy […]